ImpediMed Limited IPDQF
$0.01
$0.0040.00%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.39% | -1.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.39% | -1.28% | |||
| Cost of Revenue | 0.39% | 0.42% | |||
| Gross Profit | 0.39% | -1.52% | |||
| SG&A Expenses | 0.39% | 0.69% | |||
| Depreciation & Amortization | 0.39% | 4.61% | |||
| Other Operating Expenses | 0.39% | -19.64% | |||
| Total Operating Expenses | 0.39% | -0.60% | |||
| Operating Income | -0.39% | 0.14% | |||
| Income Before Tax | -0.39% | -7.49% | |||
| Income Tax Expenses | 0.00% | -10.87% | |||
| Earnings from Continuing Operations | -0.39% | -7.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.39% | -7.47% | |||
| EBIT | -0.39% | 0.14% | |||
| EBITDA | -7.53% | -15.11% | |||
| EPS Basic | 0.00% | 5.00% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | 0.00% | 5.00% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | 0.00% | 9.85% | |||
| Average Diluted Shares Outstanding | 0.00% | 9.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||